Biologics Registration Services

Biologics Registration Services are specialized regulatory support services that help pharmaceutical and biotech companies prepare, compile, and submit applications for the approval of biologic products (such as vaccines, monoclonal antibodies, gene therapies, and cell-based therapies) to Health Authorities like the US FDA (BLA – Biologics License Application) and the EU EMA (MAA – Marketing Authorization Application).

Biologics Registration Services – Overview

Biological products are inherently complex medicinal products, encompassing a diverse range of subcategories such as recombinant therapeutic proteins, monoclonal antibodies, cellular & gene therapy products, vaccines, and blood & blood components. Regulatory requirements for these products are extensive and differ based on product type.

Similarly, subsequent entry biologics, globally recognized as biosimilars, are subject to their own distinct regulatory frameworks. Navigating these frameworks—especially in emerging markets (RoW countries)—requires deep expertise in both product-specific and country-specific regulatory information.

Compared to major markets like the US, EU, Japan, and Australia, regulatory submissions in RoW regions (Asia, Africa, Latin America, GCC, and CIS) are more challenging due to the divergent approaches of local health authorities. Variations in submission requirements, evolving regulatory expectations, and differences in biologics/biosimilar approval pathways make market entry complex.

A dedicated biologics registration services provider can guide pharmaceutical companies through these challenges, ensuring a streamlined regulatory strategy, proper documentation, and successful approvals.

X Pharma Plus is a specialized regulatory partner with extensive experience in novel biologics, biosimilars, vaccines, blood & plasma products, and cellular & gene therapies across RoW markets. Our team provides end-to-end regulatory guidance and biologics registration services, helping sponsors navigate global complexities and achieve timely approvals.

Biologics Registration Services

“Biologics Registration Services ensure the successful preparation and submission of biologic product applications (BLA/MAA) by meeting global regulatory requirements for safety, efficacy, and quality.”

  • X Pharma Plus has a team of industry and ex-agency experts in biologics and biosimilars regulatory affairs.
  • Strong technical and scientific expertise to address regulatory challenges for various recombinant expression systems (E. coli, yeast, rCHO cells) and mammalian cell lines (Vero cells, MRC-5 cells, SPF CEF, etc.).
  • Proven success in handling combination products, such as biologics integrated with devices (PFS, pen injectors, etc.).
  • Strategic planning for global biologics and biosimilars expansion, including clinical trial design, stepwise multi-country product registration, regulatory submission strategy, and HA query management.
  • Biosimilar development strategy, covering reference product identification, analytical similarity demonstration, clinical data waivers, and minimizing local clinical data requirements.
  • Preparation of regulatory strategy and insight reports for entry into new RoW markets.
  • Expertise in agency meetings, representing sponsors to resolve scientific and regulatory issues during product registration.
  • Comprehensive biological product registration support across RoW markets (Asia, Africa, LATAM, GCC, CIS).
  • Conduct country-specific regulatory gap assessments for biological/biosimilar product registration.
  • End-to-end core dossier preparation/redaction, including country-specific formats, translations, and submission management.
  • Support for CMC variations, amendments, and supplements to different health authorities.
  • Guidance on biological product lifecycle management, including renewals and post-approval activities.
  • Comprehensive knowledge of global biologics regulatory landscapes
  • Expertise in navigating diverse and evolving regulatory requirements
  • Proven track record in successful biologics registration across multiple markets
  • Timely guidance to accelerate product approvals and market launch

Subscribe for Updates